What Happened?
Cambridge, MA-based Seres Therapeutics Appointed Lucy Glazebrook as Associate Director, Financial Reporting
About the Company
Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious, metabolic, and inflammatory diseases.
About the Person
Lucy Glazebrook is Associate Director, Financial Reporting at Seres Therapeutics. Previously, Lucy held various senior HR leadership roles in the industry.
Info Source
News
Short Profile